Reckitt Benckiser Group PLC

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Johann A. Benckiser in 1823 and is headquartered in Slough, the United Kingdom.

Reckitt Benckiser PLC said sales this year will be at the upper end of its forecasts as booming healthcare sales offset the drop-off in disinfectants as Covid concerns ease. Laxman Narasimhan, chief executive, added that while the outlook for the year remained 'highly unpredictable', the Dettol, Durex and Lysol maker was holding margins in spite of significant cost inflation.

Reckitt Benckiser ups guidance but wary of cost pressures

LONDON (Reuters) -Reckitt Benckiser Group beat first-quarter sales expectations on Friday, having increased prices to offset soaring raw material costs and flat volumes.

Reckitt price hikes drive 5.6% first-quarter sales growth

GlaxoSmithKline

Unilever

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) quarterly results on Friday may have a few pick-me-ups for investors, with numbers from the Strepsils and Nurofen maker also given context from rivals Unilever and GlaxoSmithKline earlier in the week. Top shelf of the bathroom cabinet in the news is likely to be potential news on RB's infant nutrition business, where reports emerged this week that a sale process has been kicked off.

Reckitt set up to beat Unilever, GSK with potential demerger news and bumper flu season

Reckitt Benckiser Group said on Wednesday it had begun a process aimed at transferring ownership of its Russian business, becoming the first major personal goods maker to do so following the country's invasion of Ukraine.

Reckitt says begins process 'aimed at' transferring Russian business

LONDON--(BUSINESS WIRE)--Reckitt, maker of Dettol, has been appointed as the Official Hygiene Partner of the Platinum Jubilee Pageant, as planning for the historic event in June ramps up. The celebrations are to mark Her Majesty The Queen becoming the first British Monarch to reach 70 years of service and will span several events across the Jubilee holiday. Dettol Pro Solutions, Dettol's business-to-business offering, will be supporting events across the Jubilee weekend, bringing more than 10,0

Reckitt, Makers of Dettol, Named Official Hygiene Partner of Platinum Jubilee Pageant

Diageo

Lloyds Banking Group

How to cope with the uncertainties arising from inflation, the Ukraine war, possible stagflation or even recession will have taxed many investors' minds recently. Credit Suisse asked its analysts just that question and the stocks would fare best on the criteria of lower direct exposure to Eastern Europe and eurozone cyclicality, low exposure to rising input and freight costs and strong pricing power.

Defensive stocks for uncertain times: Go with Lloyds Bank, Diageo, Reckitt Benckiser suggests Credit Suisse

While fiscal 2021 results were still mediocre and high inflation remains a problem, Reckitt Benckiser is improving. The balance sheet is improving and the company is also restructuring its portfolio towards solid, long-term growth potential. Although not a bargain at this point, the stock is still undervalued and a good long-term investment.

Reckitt Benckiser: Undervalued Stock Meets Improving Business

The company is divesting some businesses and is paying down debt.

Reckitt Benckiser: Undoing Mistakes Will Make The Company Bright Again

Two years ago Reckitt announced a big initiative to transform the company in order to rejuvenate growth.

Reckitt Benckiser: The Outlook Is Improving

Reckitt Benckiser Group plc (publ) (RBGPF) CEO Laxman Narasimhan on Q4 2021 Results - Earnings Call Transcript

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB), the maker of consumer products ranging from Durex condoms and Nurofen painkillers to Cillit Bang and Harpic bathroom and toilet cleaners, and Unilever PLC (LSE:ULVR), the group behind brands from Vaseline and Dove to Knorr and Magnum, are at the centre of the inflation narrative. Not only are both in the same sector, but both are Anglo-Dutch members of the FTSE 100 and conveniently put their results out just a week apart.

Why is Reckitt Benckiser more confident than Unilever about its inflation-beating levers?

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) said its transformation is on track as it reported revenues ahead of forecasts for 2021 and predicted growth for the current year, "despite significant commodity inflationary pressures". The consumer goods group reported net revenue of £13.2bn for the year to end-December 2021, a fall of 5.4% on the previous year, but on a like-for-like basis, the number was 3.5% higher, beating expectations.

Reckitt reports revenue ahead of expectations and forecasts growth for 2022

It is time for Reckitt Benckiser PLC to step into the limelight on Thursday, with price inflation likely front and centre for the consumer staples firm. Full-year turnover is tipped to slide 6.1% to £13.1bn and EBITDA to dive 7.3% to £3.4bn; however, good old pre-tax profit is seen recovering to £2.7bn from £1.87bn in 2020.

Reckitt Benckiser and Standard Chartered in spotlight on Thursday

Unilever PLC (LSE:ULVR) last week impressed investors with its full-year results, showing the consumer goods firm managed to pass on price inflation to consumers and continue to perform strongly – the next question is whether Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) can repeat the trick. Reckitt is set to publish full-year results on Thursday and the City is predicting a similar performance.

How long can Unilever and Reckitt pass on price inflation before losing consumers to budget brands?

Atmos Energy

Johnson & Johnson

Altria

Novartis

Northwest Natural Gas

RenaissanceRe Hlds

Verizon

Volatility is back on Wall Street, with tech suffering its worst month since 2008. No one knows how long or deep the 2022 correction will be, but prudent risk-management, not market timing is your best option for protecting your retirement nest egg.

10 High-Yield Sleep Well At Night Blue-Chips Perfect For This Correction

Reckitt Benckiser said on Friday it will sell its E45 skincare brand and related sub-brands to Karo Pharma for 200 million pounds ($267.98 million), as the British consumer goods maker shifts its focus to higher growth areas.

Reckitt to sell E45 skincare brand to Karo Pharma for $268 million

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) said it agreed to sell its E45 skincare business to Karo Pharma for an implied enterprise value of £200mln as part of its drive for higher growth. The brands had a combined net revenue of £43mln in 2021.

Reckitt to sell E45 skincare brands to Karo Pharma in £200mln deal

SYDNEY--(BUSINESS WIRE)--Dettol Pro Solutions is a B2B program by Reckitt that helps businesses of all shapes and sizes protect customers and staff from the spread of germs.

Reckitt Introduces Dettol® Pro Solutions to Help Businesses in Australia Protect People Outside the Home

Reckitt Benckiser - Still Paying For Past Mistakes

Reckitt's third quarter results were solid. But share price recovery means the market is already pricing in decent business performance.

Reckitt: The Consumer Goods Maker Looks Fairly Valued

Amgen

Alibaba

Baidu

JD.com

McKesson

SPDR S&P 500 ETF Trust

Tencent Holdings Limited

The stock market in the United States is extremely overvalued but we can find bargains in other countries. Especially tech stocks in China seem extremely cheap and Great Britain is also presenting some picks.

Hunting For Bargains Again: 9 Picks

Reckitt Benckiser is an attractively valued high-yield defensive choice in an overvalued and excessively speculative market. Reckitt Benckiser is over 200 years old, so it's built to last.

Reckitt Benckiser: One Of The Best High-Yield Blue-Chips You've Never Heard Of

Reckitt Benckiser Group on Tuesday raised its full-year forecast after reporting higher-than-expected third-quarter sales, driven by price hikes and a spurt in demand for Mucinex cold and flu remedies as well as for sexual wellness products.

Reckitt lifts sales forecast after reporting upbeat quarter

Reckitt Benckiser said it was ready to raise prices and cut costs further to maintain margin this year and in 2022 in the face of surging inflation. Costs of goods (COGS)  inflation continues to be challenging, it said, particularly in areas such as surfactants, paper, tinplate and ocean freight, and is currently running at around 10%.

News for Reckitt Benckiser Group PLC Stock (RBGLY)